FOUNDING PURPOSE STATEMENT
To advance ethical and scientific rigor in research and evidence generation... strengthening governance, policy and practice...informing human rights action, humanitarian response, health, education, heritage stewardship, and sustainable development...delivered by governments, international agencies, INGOs, civil society organizations (CSOs), commercial entities, consortia and alliances, and individuals.
The movement to evidence-based practice in the spheres of human rights, humanitarian response, health, and development is growing, welcome, and clearly justified – in terms of efficacy, ethics and equity.
For example, we see the adoption of the 2015 Sustainable Development Goals (SDGs) and its supporting Indicator Framework as a milestone in this movement. As we strive to achieve the aspirations of the SDGs [17 goals, 169 targets, 230 individual indicators], the associated tracking of progress and impact will drive an unprecedented level of new and re-engineered monitoring, data collection, research and analysis globally. [see, for example, Annex 2 on SDG Indicators associated with children and adolescents]
Complementing this forward trend, there has been significant evolution in the last two decades in the body of international conventions, laws, professional codes, statements of principles, and other formulations guiding the ethical conduct of research, evaluation, data collection and secondary analysis involving human participants (or datasets derived from such work). [see Annex 1 for a compilation]
Equally, there has been growth of various types of ethical review bodies and regulatory mechanisms to provide assessment of and guidance on scientific rigor, ethical resilience, and other dimensions of research activity. Many of these ethical review bodies operate within academic institutions or governmental/regulatory contexts, while others operate within international agencies or INGOs, or independently.
Despite the legal/treaty/conventions framework and oversight mechanisms referenced above, our assessment is that much research, evaluation, data collection and analysis in these fields proceeds without any independent ethical review, and/or with research design and methodologies that are insufficiently rigorous and not well-aligned to the research question involved and the specific geographical/ cultural context where the work will proceed.
In response to the above, we have formed a new Foundation to host a global, independent, virtual ethics review and research services capability with the purpose stated above. We believe that researchers and their organizations will engage independent review of their proposed work if it is available via an efficient, timely, and cost-effective process, and further supported by consultative services to strengthen research design, assure ethical resilience, and forge solutions where needed across the evidence generation life cycle.
Centers & Programs
The Foundation operates through a portfolio of Centers AND PROGRAMS to focus our work.
Center for Disaster and Humanitarian Ethics
Our Center for Disaster and Humanitarian Ethics is in formation and will focus on ethics, evidence generation, and policy involving health interventions, human rights, and humanitarian response to the full range of natural and manmade disasters and complex emergencies.
Donal O’Mathuna, PhD, a Fellow of the Foundation and a member of its Board of Directors, will lead this new Center as its Founding Director, and be responsible for building a team of GE2P2 Global Foundation Fellows and Associates who will conduct the research and analytical work of the new Center, and provide consultation to international agencies, INGOs, civil society organizations and donors involved in disasters and humanitarian action.
If you would like to support the work of the Center for Disaster and Humanitarian Ethics click here.
CENTER FOR VACCINE ETHICS AND POLICY (CVEP)
Founded as the Ethics of Vaccine Project in 2006, CVEP engages the full life-cycle of issues around global immunization and vaccines:
building and refining the ethical frameworks that help assure that policy proceeds from values and aligns with their implications,
analyzing and communicating about vaccine evidence, ethics and policy in scholarly journals, the media and in other fora,
innovating new analytical, visualization and decision approaches to address these issues, and
convening the full vaccine community to consider evidence, ethics and practical solutions, addressing opportunity and performance.
CVEP also offers a knowledge-sharing service through publication of Vaccines and Global Health: The Week in Review.
This comprehensive weekly digest aggregates news, events, announcements, peer-reviewed articles and research in the global vaccine ethics and policy space. Content is selected from key governmental, NGO, international organization and industry sources, key peer-reviewed journals, and other media channels.
This Week in Review now reaches over 2,500 leaders in the vaccine space globally each week through direct email distribution. These leaders operate in diverse spheres including government, the NGO/ONG community, UN agencies and other intergovernmental bodies, think tanks and policy organisations, academia, philanthropy, and industry.
Our continuing intent is to support broad literacy and current awareness at the leadership level across the global vaccine community. Specifically, we believe that this digest – delivered each weekend – supports stronger, evidence-based policy analysis and decision-making, enhances research strategy, and functions as a productivity tool for leaders whose time to devote to reading broadly is limited.
If you would like to learn more about the work of CVEP, please click here. If you would like to support the work of the Center for Vaccine Ethics and Policy, click here. If you like to support for our weekly digest -- Vaccines and Global Health: The Week in Review -- click here.
Center for Ethics and Policy on Access to Medicines
Our Center for Ethics and Policy on Access to Medicines conducts research, convenes symposia and workshops, publishes, and develops ethical guidance and policy concerning fair, equitable and effective access to pharmaceutical products including drugs, biologics, vaccines, essential medicines and medical devices.
The Center’s focus areas include general bioethical issues associated with research, discovery, and clinical trials for investigational medicines; compassionate use/pre-licensure/expanded access programs, and access to vaccines and essential medicines in low resource settings and humanitarian contexts globally.
GE2P2 Global also works in a lead advisory capacity with commercial, not-for-profit/NGO and public sector biopharma organizations to address bioethics and policy issues and challenges throughout the full life cycle of their R&D/clinical development, licensure, manufacturing, marketing, distribution, and overall post-marketing management.
In June 2017, the Center has launched an advisory services program supporting the full life cycle of Compassionate Use/Expanded Access Program [EAP] initiatives -- click here.
FELLOWS of the Foundation
To address our purpose and mission, the Foundation engages the competencies, experience, and insights of a global network of elected “Fellows" of the Foundation.
To engage its purpose/mission, the Foundation draws on the competencies, experience, and insights of a global network of “Fellows" of the Foundation who contribute to strategy, research, governance and programs.
Fellows will include academic, agency and government leaders, field practitioners, scientists, researchers, ethicists, domain and cultural context experts, scholars in the social and bio sciences and the humanities, knowledge management experts, and many others. Fellows may be independent or be functioning in government, academic, agency, NGO, or commercial contexts.
Fellows and Associates are elected for one-year terms and such terms may be extended by the Board at its discretion.
All Fellows and Associates participate under the leadership and direction of the President, contribute to governance by providing guidance on strategic direction as facilitated by the board, and are selectively convened as team members around specific research, projects and consultative work.
Fellows and Associates are recognized on the Foundation website and convene from time-to-time and at least annually via electronic or physical meetings for knowledge sharing, to review strategy, and to affirm member guidance to the Board.
The Board is considering a membership class for organizations – providing NGOs, CSOs, international agencies and commercial organizations with a means to support and participate in the Foundation. Such organization members would have a designated individual as their official, voting representative. More on this soon...
GOVERNANCE & LEADERSHIP
The Foundation is governed by a Board of Directors. The composition of the Board strives to represent a broad range of disciplines and research agendas across human rights, humanitarian response, health, heritage stewardship, education and development, and across major geographies and organization types.
The Foundation's Board of Directors is in formation
board members of the GE2P2 Global Foundation
Arthur L. Caplan, PhD
Founding Board Member
The Drs. William F and Virginia Connolly Mitty Professor and founding head of the Division of Bioethics at New York University Langone Medical Center
DAVID R CURRY, MS
FOUNDING BOARD MEMBER & President
Executive Director, Center for Vaccine Ethics and Policy
Managing Principal, davidrcurryAssociates
Kristen A. Feemster, MD, MPH, MSHPR, FAAP
Division of Infectious Diseases and Director of Research for the Vaccine Education Center
Children’s Hospital of Philadelphia
;Medical Director, Philadelphia Department of Health Immunization Program
Robert I. Field, PhD, MPH, JD
Professor of Law and Professor of Health Management and Policy
Kline School of Law and Dornsife School of Public Health
donal O'MATHUNA, PHD
Senior Lecturer in Ethics, Decision-Making & Evidence
School of Nursing & Human Sciences, Dublin City University (DCU)
Barbara K Redman, PhD, MBE
Associate, Division of Medical Ethics
New York University
FINANCIALS & REPORTING
We will post our annual reports, financial statements and other content supporting our commitment to full transparency. As the foundation was formed in June 2016, we have not yet posted any documents. Please visit again soon.
Statement of Independence
June 2016 | The GE2P2 Global Foundation, its programs and operating units maintain an academic affiliation with the Division of Medical Ethics at NYU School of Medicine, NYU Langone Medical Center. We will seek additional affiliations and alignments with academic, agency, NGO, CSO and other organizations as may further the purpose of the Foundation, and clearly communicate about such affiliations
Our work is focused on advancing ethical and scientific rigor in research and evidence generation for governance, policy and practice in human rights action, humanitarian response, health, education, heritage stewardship, and sustainable development – serving governments, international agencies, INGOs, civil society organizations (CSOs), commercial entities, consortia and alliances.
This work depends on in-kind and financial support from a range of sources, including foundations, NGOs, academic institutions, international agencies, the vaccine industry, other commercial organizations, and individual donors.
We strive to balance and diversify the sources of support we accept in pursuing project work, publishing, convening symposiums and meetings, and conducting research. We are committed to transparency in acknowledging the sources of support for work we undertake.
Regardless of the source, form or scale of support we receive, we do not accept and will not operate under any conditions which interfere with our independence in electing, designing or conducting our work, or in publishing and disseminating our findings.
We are particularly mindful of actual and potential conflicts of interest which may affect the ability of anyone associated with the foundation to participate in specific work.
We will uniformly communicate any and all conflicts we identify to assure that all work products are transparent on this as well sources of support to assure maximum transparency.